Amplification of 3q26∼qter correlates with tumor progression in head and neck squamous cell carcinomas

被引：27
|
作者：
Hashimoto, Y
Oga, A
Kawauchi, S
Furuya, T
Shimizu, N
Nakano, T
Imate, Y
Yamashita, H
Sasaki, K
机构：
[1] Yamaguchi Univ, Sch Med, Dept Pathol, Ube, Yamaguchi 7558505, Japan
[2] Yamaguchi Univ, Sch Med, Dept Otolaryngol, Ube, Yamaguchi 7558505, Japan
来源：
CANCER GENETICS AND CYTOGENETICS | 2001年 / 129卷 / 01期
关键词：
D O I：
10.1016/S0165-4608(01)00425-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Biological characteristics of malignant tumors including head and neck squamous cell carcinoma (HNSCC) are greatly affected by genetic alterations. However, the relationship between chromosomal aberrations and pathologic tumor stage in HNSCC has not been elucidated. In 32 patients, DNA sequence copy number aberrations (DSCNA) were surveyed by comparative genomic hybridization (CGH) combined with a microdissection method. The average number of DSCNA was 15.3 per tumor and increased with tumor stage (P < .05). DNA copy number gain was detected at 3q26 similar to qter in 29 tumors (91%), and 13 of these tumors displayed marked DNA amplification. Tumor stage was linked with this amplification (P < .05). The increase in DSCNA and amplification of 3q26 similar to qter are likely to be useful markers for estimating tumor progression in HNSCC. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码：52 / 56
页数：5
相关论文
共 50 条
  • [21] Amplification of genes at 11q13 in relation to HPV status in head and neck squamous cell carcinomas
    Rodrigo, J. P.
    Hermida-Prado, F.
    Tirados Menendez, S.
    Granda-Diaz, R.
    Alonso Duran, L.
    Leon, X.
    Alemany, L.
    Mena, M.
    Del Rio Ibisate, N.
    Astudillo, A.
    Garcia-Pedrero, J. M.
    RADIOTHERAPY AND ONCOLOGY, 2019, 132 : 52 - 52
  • [22] Evaluation of microsatellite amplifications at chromosomal locus 3q26 as surrogate marker for premalignant changes in mucosa surrounding head and neck squamous cell carcinoma
    Brieger, Juergen
    Kastner, Jan
    Gosepath, Jan
    Mann, Wolf J.
    CANCER GENETICS AND CYTOGENETICS, 2006, 167 (01) : 26 - 31
  • [23] ANALYSIS OF GENE AMPLIFICATION IN HEAD-AND-NECK SQUAMOUS-CELL CARCINOMAS
    LEONARD, JH
    KEARSLEY, JH
    CHENEVIXTRENCH, G
    HAYWARD, NK
    INTERNATIONAL JOURNAL OF CANCER, 1991, 48 (04) : 511 - 515
  • [24] New Tumor Budding Evaluation in Head and Neck Squamous Cell Carcinomas
    Cacchi, Claudio
    Fischer, Henrike J.
    Wermker, Kai
    Rashad, Ashkan
    Jonigk, Danny D.
    Hoelzle, Frank
    Klein, Maurice
    CANCERS, 2024, 16 (03)
  • [25] Identification of ZASC1 encoding a Kruppel-like zinc finger protein as a novel target for 3q26 amplification in esophageal squamous cell carcinomas
    Imoto, I
    Yuki, Y
    Sonoda, I
    Ito, T
    Shimada, Y
    Imamura, M
    Inazawa, J
    CANCER RESEARCH, 2003, 63 (18) : 5691 - 5696
  • [26] Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas
    Rodrigo, J. P.
    Garcia-Carracedo, D.
    Garcia, L. A.
    Menendez, S. T.
    Allonca, E.
    Gonzalez, M. V.
    Fresno, M. F.
    Suarez, C.
    Garcia-Pedrero, J. M.
    JOURNAL OF PATHOLOGY, 2009, 217 (04): : 516 - 523
  • [27] Clinical significance of the expression and amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas
    Alija, G. Alvarez
    Menendez, S. T.
    Garcia-Carracedo, D.
    Allonca, E.
    Mancebo, G.
    Suarez, C.
    Rodrigo, J. P.
    Garcia-Pedrero, J. M.
    EJC SUPPLEMENTS, 2010, 8 (05): : 41 - 41
  • [28] Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas:: Correlation with clinical outcome
    Rödel, C
    STRAHLENTHERAPIE UND ONKOLOGIE, 1998, 174 (12) : 642 - 643
  • [29] Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: Correlation with clinical outcome
    Muller, D
    Millon, R
    Velten, M
    Bronner, G
    Jung, G
    Engelmann, A
    Flesch, H
    Eber, M
    Methlin, G
    Abecassis, J
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (13) : 2203 - 2210
  • [30] SOX2 identified as a target gene for the amplification at 3q26 that is frequently detected in esophageal squamous cell carcinoma
    Gen, Yasuyuki
    Yasui, Kohichiroh
    Zen, Yoh
    Zen, Keika
    Dohi, Osamu
    Endo, Mio
    Tsuji, Kazuhiro
    Wakabayashi, Naoki
    Itoh, Yoshito
    Naito, Yuji
    Taniwaki, Masafumi
    Nakanuma, Yasuni
    Okanoue, Takeshi
    Yoshikawa, Toshikazu
    CANCER GENETICS AND CYTOGENETICS, 2010, 202 (02) : 82 - 93
12345